icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
 
 
 
Tropifexor (TXR), an FXR Agonist for the Treatment of NASH - Interim Results from First Two Parts of Phase 2b Study FLIGHT-FXR
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF

1127181

1127182

1127183

1127184

1127185

1127186

1127187

1127188

1127189